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OBJECTIVE
The objective of this study was to examine 1) whether teens’ glycemic control
and adherence to type 1 diabetes treatment regimen worsen during the transition
from late adolescence to emerging adulthood, and 2) whether teens’ executive
function (EF), as measured by performance and self-reported problems with EF, is
predictive of these changes (after controlling for general intelligence).
RESEARCH DESIGN AND METHODS
High school seniors with type 1 diabetes (N = 236; mean age 17.74 years) were
assessed at three yearly time points. At baseline, during the senior year of high
school, participants completed a self-report measure of problems with EF and
performance-based measures of EF and general intelligence (IQ). Glycemic control
was determined on the basis of results collected from HbA1c assay kits, and teens
reported their adherence at all three time points.
RESULTS
HbA1c increased significantly across the three time points and adherence declined.
EF performance was not associated with adherence or HbA1c at baseline, nor with
changes in adherence over time. However, better EF performance predicted slower
increases in HbA1c over time (i.e., slope) while controlling for IQ. Teens’ self-
reported problemswith EFwere associatedwithworse glycemic control andpoorer
adherence at baseline (i.e., intercept), but they did not predict changes in either
HbA1c or adherence over time (i.e., slope).
CONCLUSIONS
Abilities involved in performance on EF tests may be one resource for maintaining
better glycemic control during the transition to emerging adulthood. Assessment
of such EF abilities may allow for the identification of individuals who are most at
risk for deterioration of glycemic control during this transition.
The transition between late adolescence and emerging adulthood has been de-
scribed as a “high-risk” time for individuals managing type 1 diabetes (1), charac-
terized by higher levels of HbA1c and poorer adherence than for individuals at other
developmental time periods (2). Longitudinal studies indicate that glycemic control
(3,4) and adherence (5) deteriorate during adolescence. The few studies that have
examined longitudinal trajectories extending into early young adulthood suggest
these vary greatly across individuals, with some displaying increases in HbA1c during
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adolescence and young adulthood (6,7),
others showing improvements during
young adulthood (6,7), and yet others
maintaining fairly stable (high or low)
levels of glycemic control and adherence
across time (6–8). Understanding factors
that contribute to such variability may
help to identify those who are at highest
risk for poor diabetes self-management
during this transitional time.
Cognition may be an important factor
in understanding adherence and glyce-
mic control trajectories during the tran-
sition to emerging adulthood, a factor
that to our knowledge has not yet been
examined. During emerging adulthood,
defined as the period from ages 18 to
25 years (9), teens need to remember,
plan, and execute an intensive diabetes
treatment regimen, often while moving
away from home, entering college or the
workforce, and establishing new rela-
tionshipswith peers (10). Cross-sectional
research has demonstrated that gen-
eral cognitive abilities and executive
function (EF) abilities such as planning,
organization, and working memory may
provide adolescents with resources for
maintaining better glycemic control and
adherence. Specifically, in adolescents,
more reported problems with EF (mea-
sured on the basis of reports by parents
or youths) are associated with poorer
adherence and poorer glycemic control
(11–15). Previous cross-sectional results
from the sample used in this study showed
that lower scores on performance-based
measures of EF were associated with
poor glycemic control during the senior
year of high school (15). Cross-sectional
findings are supported further by lon-
gitudinal research showing that fewer
parent-reported problems with EF
characterized a low-risk group of ado-
lescents who maintained good glyce-
mic control across a 3-year time frame
(16).
What ismissing from the literature are
longitudinal studies examining how EF
specifically (controlling for general cog-
nitive abilities) may be a resource for
diabetes management across the transi-
tion to emerging adulthood, compar-
ing performance-based measures to
self-reported measures of problems
with EF. Such research is important for
three reasons. First, the vast majority of
studies used questionnaires (self- or
parent-report) that are purported to
assess neurocognitive processes, but
such measures are only modestly related
to performance-based measures of EF
(17,18). Thus, although questionnaires
are easier to administer in clinic settings
than performance-based measures, it
is uncertain whether both are similarly
predictive of changes in adherence and
glycemic control over time. Second, stud-
ies have predominantly used parent-
reported EF because of the young age
of children, their cognitive impairments,
or both (18). During emerging adult-
hood, teens’ reports may be crucial to
identifying those who are at risk, as
parents often no longer attend their
teens’ health care visits and may be
less knowledgeable about teens’ daily
lives. Finally, to understand whether EF
specifically predicts diabetes manage-
ment, more general cognitive abili-
ties such as IQ must be statistically
controlled, as IQ underlies many daily
activities and is associated with both self-
report and performance-based measures
of EF (19).
This longitudinal study fills this im-
portant gap by examining how both
self-reported problems with EF and
performance-based measures of EF
(while controlling for intelligence) pre-
dict longitudinal trajectories of type 1
diabetes management during the tran-
sition from late adolescence to early
emerging adulthood. We first examine
whether HbA1c and adherence system-
atically change across three annual time
points. We anticipated that significant
increases in HbA1c and decreases in
adherence would occur, but that the
rate of deterioration would vary across
individuals. Next, we assessed whether
teens’ reports of problems with EF and
performance-based measures of EF ob-
tained during the senior year of high
school (controlling for intelligence) pre-
dicted changes in HbA1c and adherence
across the three time points. We antic-
ipated that both fewer self-reported
problems with EF and higher EF perfor-
mance would predict slower increases in
HbA1candslowerdecreases inadherence
over time.
RESEARCH DESIGN AND METHODS
Participants
High school seniors with type 1 diabe-
tes were recruited for a 2-year longitu-
dinal, multisite study investigating the
transition to early emerging adult-
hood. Participants were recruited from
outpatient pediatric endocrinology clin-
ics during clinic visits or by phone in
two southwestern U.S. cities. Youths
were eligible if they had been diag-
nosed with type 1 diabetes for at least
1 year (mean 6 SD time since diagnosis
7.35 6 3.88 years; 94% of teens had
diabetes for $2 years), spoke English as
their primary language,were in theirfinal
year of high school, livedwith a parent or
parentalfigure at baseline (68.4% lived at
homewithboth parents; 27.1%,with one
biological parent; 4.5%, with adoptive
parents or grandparents), would be able
to have regular contact with parents or
the parental figure over the subsequent
2years, andhadnocondition thatwould
prohibit study completion (e.g., severe
intellectual disability, blindness). Ado-
lescents who had dropped out of high
schoolwere eligible if theymet all other
criteria. Of the 507 qualified individ-
uals we approached, 301 (59%) agreed
to participate. Of those who initially
agreed, 247 (82%) enrolled in the
study. Reasons for not participating
included lack of interest (33%) or being
too busy during their senior year to
participate (34%); 20% declined to
give a reason. The institutional review
board at one site permitted data col-
lection to allow comparisons between
those who did and those who did not
participate. We found no differences
in HbA1c, time since diagnosis, sex, or
pump status (P . 0.05). However,
participants were slightly younger
(mean 6 SD 17.77 6 0.43 vs. 17.91 6
0.48 years; t[203] = 2.27; P = 0.02) and
were more likely to be Hispanic (21% vs.
11%; x2 [1] = 3.88; P = 0.049) than
nonparticipants.
Procedure
The study had institutional review board
approval; parents provided consent and
teens provided consent or assent (those
who assented provided consent after
they turned 18). EF performance and IQ
were assessed in the laboratory, and an
online survey measured self-reported
problems with EF and adherence. Teens
were paid $50 for the first two annual
assessments and $75 for the third as-
sessment. At each time point, teens
reported illness and demographic var-
iables, including their pump status,
with whom they were living, and their
health insurance. Because extreme hyper-
glycemia and hypoglycemia can affect
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cognitive performance (20,21), blood
glucose levels were checked before per-
formance measures were completed. If
blood glucose levels were outside the
range 75–400 mg/dL, participants took
steps to normalize blood glucose; test-
ing was rescheduled for one participant
who could not bring blood glucose in
range. Blood glucose levels during the
testing sessions were not related to
performance measures of EF and IQ
(r , 0.13; all P . 0.11).
Measures
EF
Self-reported problems with EF were
measured with the Behavior Rating
Inventory of Executive Function–Self-
Report. This measure is normed for
respondents between 5 and 18 years
of age (22), and previous research has
demonstrated its high internal consis-
tency (a = 0.72–0.96). Participants rated
items (0 = never, 1 = sometimes, 2 =
often) to indicate how frequently they
experienced each problem over the pre-
ceding 6 months. Subscales were com-
bined into a global executive composite
scorewith good reliability (a=0.95). Age-
and sex-corrected t scores taken from
the manual (22) were used in analyses.
Performance-based EF was measured
through the use of four subtests from
the Delis-Kaplan Executive Function Sys-
tem battery (23). We assessed widely
recognized components of EF: set main-
tenance and working memory, assessed
with the Trail Making Test (letter–number
sequencing condition completion time);
response inhibition and cognitive con-
trol, assessed with the Color-Word Inter-
ference Test (inhibition and inhibition/
switching condition completion times);
and initiation and generative fluency,
assessed with tests of verbal fluency
(correct responses for the letter and
category conditions) and design flu-
ency (correct responses for each of
the three conditions). This assessment
battery yielded eight executive scores.
Themean of norm-based, age-corrected,
scaled scores (as described in the test
manual [23]) was computed to gen-
erate a single EF performance score.
In this sample, the Cronbach a for this
composite was 0.83.
General IQ
Teens completed the Vocabulary sub-
test of the Wechsler Adult Intelligence
Scale–Fourth Edition (24), whichweused
to estimate crystallized IQ (25). This sub-
test correlates 0.91–0.92 with verbal IQ
and 0.79–0.81 with full-scale IQ in this
age-group (24). Reported split-half re-
liability for the Vocabulary subtest is
0.93 for teens aged 16–19 years in the
normative sample (24). We analyzed
norm-based, age-corrected, scaled scores
(24).
Adherence
Teens’ reports of adherence to their dia-
betes regimen were measured through
the use of the Diabetes Behavior Rating
Scale, a 37-item scale assessing self-
management behaviors (e.g., meal plan-
ning, blood glucose testing, exercise,
the amount and timing of insulin) and
components of problem-solving (e.g.,
adjusting insulin doses depending on
blood glucose levels or food intake)
(26). This measure correlates highly
with more time-intensive interview mea-
sures (26). In this study, the scale had
good reliability (a = 0.84 for teens who
use an insulin pump; a = 0.86 for teens
who do not use a pump). Scores were
computed as proportions ranging from
0 to 1 (higher scores reflected better
adherence) (26).
Glycemic Control
HbA1c was measured on the day of
cognitive testing and at later time points
through the use of mail-in HbA1c kits
(provided and processed by CoreMedica
Laboratories, accredited by the Col-
lege of American Pathologists; www
.coremedicalabs.com). This approach
was chosen over obtaining HbA1c
from medical records to ensure that
HbA1c was measured on the day of
cognitive testing for all participants,
that the same procedures were used
to measure HbA1c across time points,
and that HbA1c measures could be ob-
tained even from those who were not
receiving routine care. The kit was com-
pleted by the teen at baseline after they
received instructions from a trained
research assistant, who observed test
completion. This measure was highly
correlated with HbA1c obtained from
point-of-care assays noted in the med-
ical records at baseline (r = 0.74; P ,
0.001).
Analytic Plan
Missing data for key study variables
ranged from a low of 1% to a high of
12%. To account for missing data, we
generated five data sets through multi-
ple imputation (MI) (27) for individuals
who provided survey data. We did not
impute data for an individual who was
missing all data from one time point. The
MI procedure included variables beyond
those included in the analyses presented
here to help ensure that an adequate
missing-at-random model was gener-
ated. The lowest efficiency was 0.942,
suggesting that the MI procedure across
fivedata sets adequately recoveredmiss-
ing data.
Unconditional linear growth curve
models of HbA1c and adherence were
conducted with the MIXED command in
SPSS software version 24 (IBM). Full
maximum likelihood was applied to ex-
amine changes in HbA1c and adherence
across the three time points.We included
random effects on the intercept and
slope, with baseline coded as 0, such
that the intercept represented the mean
value of the dependent variable at time
1. Next we created conditional growth
curve models to determine whether
EF predicted baseline levels (i.e., inter-
cept) and changes in HbA1c or adherence
(i.e., slope); we analyzed separate mod-
els for EF performance and self-reported
problems with EF. All independent var-
iables were centered at their mean to
facilitate interactions (e.g., EF predict-
ing slope or a time effect). We examined
the conditional effects after controlling
for IQ. Time since diagnosis and insulin
pump status (0 = no, 1 = yes) measured
at baseline were included as covariates
in analyses of HbA1c. Because 13% of in-
dividuals changed their pump status
over time, pump status was analyzed
as a time-varying covariate and results
were similar to those with pump status
controlled only at baseline.
No significant effects were found
for sex across all analyses (P . 0.10).
Hispanic/Latino participants had higher
HbA1c than did Caucasians at baseline
(8.97% vs. 8.10%; P , 0.05), but the
slope of HbA1c did not differ between
the groups. Analyses conducted with and
without ethnicity as a covariate yielded
no differences in results. Living in the
parental home was not associated with
either HbA1c or adherence, nor did it al-
ter the trajectories of these variables
across time. Because these covariates
were either not significant or did not
alter results, they were not included in
further analyses.
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RESULTS
Preliminary Analyses
Consistent with the population at par-
ticipating clinics, 75.2% of the full sam-
ple (N = 247) identified as non-Hispanic
white, 14.2% as Hispanic, and 4.8% as
African American; the remainder identi-
fied as Asian/Pacific Islander, American
Indian, or more than one race. Patients
were ameanof 17.76 years old (SD = 0.39
year), and 60% were female.
This study included 220 teens with
complete survey data at two or more
annual assessments and valid scores for
EF performance, IQ, and self-reported
problems with EF at baseline. Educa-
tional background of mothers and fa-
thers was, on average, some college or
higher (Table 1). Around 40% of teens
were using a pump over time, and about
half were living in the parental home at
times 2 and 3. The majority of teens
reported being either fully or partially
covered by their parents’ insurance. The
220 teens included in these analyses
(63% female; mean 6 SD age 17.77 6
0.39 years) did not differ from the 16
who were not included (because they
completed only a single time point) on
primary study variables at baseline, in-
cluding adherence, self-reported prob-
lems with EF, or EF performance (P .
0.4); however, those included had
lower HbA1c at baseline than those
who completed a single time point
(8.23% vs. 8.92%; t = 2.36; P , 0.05).
Teens had, on average, HbA1c values
above American Diabetes Association
recommendations (HbA1c #7.5% [28])
in all years of the study (Table 1). Teens’
reports of problems with EF and of EF
performance and IQ were in the mean
range relative to norms (22–24). More
self-reported problems with EF were
modestly associated with poorer EF per-
formance (r = 20.28; P , 0.01).
EF Performance and Self-Reported
Problems With EF Predicting Change
in HbA1c
Growth models examining linear change
in HbA1c are presented in Table 2. The
time effect in the unconditional growth
model indicated that HbA1c increased
significantly over time, with a 0.507%
increase in HbA1c for each year past
the senior year of high school (baseline).
Significant random effects indicated
between-person variability at baseline
(intercept) and in changes in HbA1c across
time (slopes). Covariate analyses indi-
cated that individuals using insulin pumps
had lower HbA1c than those not using
pumps.
Conditional growth models indicated
that higher IQ was associated with
lower HbA1c at baseline. Further, EF
performance predicted change in HbA1c
Table 1—Descriptive statistics for demographics and primary measures
Baseline Year 2 Year 3
Mother’s education, %
High school or less 13.900 d d
Some college 42.800 d d
Bachelor’s or higher 42.500 d d
Father’s education, %
High school or less 21.300 d d
Some college 28.800 d d
Bachelor’s or higher 48.300 d d
Uses pump, % 43.600 45.000 51.200
Living in parental home, % 100.000 52.510 48.470
On parents’ insurance, % 75.000 78.600 72.000
Mean SD Mean SD Mean SD
HbA1c
In % 08.218 1.668 08.937 1.976 09.229 2.052
In mmol/mol 66.000 74.000 77.000
Self-reported EF problems 54.306 10.524 d d
EF performance 11.312 2.038 d d
IQ 11.512 3.317 d d
Adherence 00.609 0.123 00.587 0.132 00.589 0.150
Scores for self-reported EF problems, EF performance, IQ, and adherence are based on the
tests described in RESEARCH DESIGN AND METHODS. Dashes indicate that the variable was only measured
at baseline.
Table 2—Growth curve model for HbA1c
HbA1c growth curve models b SE Random effect Variance
Unconditional model
Intercept 8.267 0.108** 1.368 0.216**
Years since diagnosis 0.038 0.025
Pump status (0 = MDI, 1 = pump) 20.844 0.196**
Time (0 = time 1) 0.507 0.072** 0.347 0.101**
Conditional models
EF Performancea
Intercept 8.271 0.104** 1.196 0.198**
Years since diagnosis 0.034 0.024
Pump Status (0 = MDI, 1 = pump) 20.662 0.191**
Time (0 = Time 1) 0.502 0.071** 0.340 0.097**
IQ
On Intercept 20.096 0.038*
On Slope 0.048 0.026
EF Performance
On Intercept 20.066 0.060
On Slope 20.096 0.043*
Self-reported EF problemsa
Intercept 8.269 0.102** 1.105 0.192**
Years since diagnosis 0.035 0.024
Pump status (0 = MDI, 1 = pump) 20.706 0.189**
Time (0 = time 1) 0.499 0.072** 0.382 0.101**
IQ
On Intercept 20.107 0.033**
On Slope 0.020 0.023
Self-reported EF problems
On Intercept 0.029 0.010**
On Slope 0.002 0.007
MDI, multiple daily injections. aControlling for IQ. *P , 0.05; **P , 0.01.
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(EF performance on slope effect; Table
2), indicating that EF performance pre-
dicted significantly different slopes in
HbA1c across time. As displayed in Fig. 1,
individuals with higher EF performance
at baseline experienced slower in-
creases in HbA1c across the three time
points (plotted 1 SD above and below
the mean EF performance). Simple
slope analyses revealed that both slopes
were significantly different from zero,
indicating that both those with better
and those with poorer EF performance
experienced increases in HbA1c across
the three time points. As predicted,
however, those with better EF perfor-
mance deteriorated slower (slope of
0.361%) than those with poorer EF per-
formance (slope of 0.622%).
A similar analysis was conducted us-
ing self-reported problems with EF. As dis-
played in Table 2, both higher IQ and fewer
self-reported problems with EF were asso-
ciated with lower HbA1c at baseline. How-
ever, self-reported problems with EF did
not predict changes in HbA1c across time.
EF Performance and Self-Reported
Problems With EF Predicting Change
in Adherence
Growth models examining linear change
in adherence are presented in Table 3.
The unconditional growth model indi-
cated that adherence decreased signif-
icantly over time, with a very small
decrease of 0.012 for each year past
the senior year of high school. Random
effects were statistically significant, in-
dicating between-person variability at
baseline (intercept) and in changes in
adherence across time (slope). Neither
IQ nor EF performance predicted inter-
cepts or slopes for adherence across
time.
A similar analysis was conducted using
self-reported problems with EF. As dis-
played in Table 3, greater self-reported
problems with EF were associated with
lower adherence at baseline. No variable
predicted slopes of adherence across
time.
CONCLUSIONS
The findings of this study support the
view of the transition to early emerging
adulthood as a “high-risk” time for dia-
betes management (1). HbA1c increased
substantially during early emerging
adulthood. This increase is clinically con-
cerning given that at baseline teens were
already well above American Diabetes
Association–recommended HbA1c val-
ues. Substantial variability existed in
the slopes of HbA1c, with HbA1c in
some individuals increasing more rap-
idly than in others, consistent with the
growing literature on variability in gly-
cemic control across the transition to
emerging adulthood (5–7). Teens also
reported lower adherence during their
senior year than was reported in a sample
of 12- to 18-year-olds (0.61 vs. 0.75out of
1.00) (26), with further modest declines
in adherence across time.
This study is to our knowledge the
first to demonstrate that better scores
on a performance-based measure of EF
predict slower increases in HbA1c over
time, even when controlling for intel-
ligence. Our participants scored within
the mean range for EF relative to na-
tional norms, indicating that EF perfor-
mance even within the normal range
is important in understanding changes
in HbA1c across time. EF performance
likely would be more predictive if exam-
ined in individuals with scores in the
clinically impaired range (29). The fact
that the performance-based measure
predicted change even when control-
ling for intelligence provides evidence
that EF specifically, rather than cog-
nition more generally, is predictive of
HbA1c changes across time. Although
performance-based EF scores predicted
changes in HbA1c across time, the slope
of HbA1c still varied significantly. Such
findings suggest that other factors are
involved in changes in HbA1c during
emerging adulthood, such as health
care appointments and changes in pa-
rental involvement or other supportd
many of which we did not have access to
in this study (e.g., severe hypoglycemic
episodes, diabetic ketoacidosis). These
factors will be important to include in fu-
ture research.
Self-reported problems with EF were
associated with HbA1c and adherence at
baseline, but not with changes in HbA1c
or adherence across the 2-year period.
The modest correlation between EF per-
formance and self-reported problems
with EF in this study is consistent with
the broader literature about younger
children and those with developmen-
tal disorders (18). The neurocognitive
processes needed for execution of self-
reported versus performance-based
tasks likely differ, as functional MRI
research demonstrates that such mea-
sures activate different neuroanatomi-
cal regions (30). Self-report measures
Figure 1—Changes in HbA1c over time as a function of EF performance (EF Perform; 1 SD above
and below the mean).
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of EF problems have been described as
tapping typical behavior in real-world
contexts and reflect factors other than
EF abilities, including contextual factors
such as available resources (e.g., support
from parents) or the complexity of one’s
daily life. By contrast, performance-
based EF measures reflect underlying
neurocognitive capacity assessed under
constrained, structured conditions (18),
and thus they are relatively noncon-
founded by contextual factors. The re-
sults suggest that it is the extent to
which emerging adults can engage in
EF optimally across contexts that allows
them to maintain good glycemic control
throughout emerging adulthood. The
discrepancy between self-reported EF
performance and problems with EF
could be due to teens underestimat-
ing or misremembering their problems
with EF. Scores from self-report and
performance-based measures of EF
clearly represent different constructs
and should not be interpreted as com-
mensurate (17,18).
Neither teens’ reported EF perfor-
mance nor problems with EF were pre-
dictive of changes in adherence across
time; this perhaps is attributable to the
limited changes in self-reported adher-
ence across the 2 years. The large in-
creases in HbA1c and the very modest
declines in adherence indicate that
emerging adults’ perceptions of adher-
ence do not correspond with their HbA1c
values. Young emerging adults may be
adhering in the same manner as they
did during adolescence but without
the same beneficial result for HbA1c.
Contextual changes in early emerging
adulthood, including the reduced in-
volvement of parents, may alter the
efficacy of their adherence behaviors.
In addition, emerging adults’ judgments
of their adherence are only modestly
related to more objective measures
such as blood glucose tests (31). Future
research on individuals in this age range
would benefit from objective measures
such as records downloaded from gluc-
ometers, continuous glucose monitors,
or insulin pumps, which were not avail-
able for this sample.
The current findings have numerous
clinical implications. First, teens’ EF per-
formance may be a useful indicator of
who is at increased risk for deteriorations
in glycemic control during the transition
out of high school. The fact that only EF
performancedrather than self-reported
problems with EFdwas predictive is
important, as most research has used
self- or parent-report measures such as
the Behavior Rating Inventory of Exe-
cutive Function. Although traditional
measures of EF performance cannot
realistically be administered by medi-
cal personnel, the field of clinical
neuropsychology is actively developing
computer-administered tests that could
be adapted for clinical use (32). Cur-
rently, however, batteries that are par-
tially (e.g., the National Institutes of
Health Executive Abilities: Measures and
Instruments for Neurobehavioral Eval-
uation and Research or the Cognition
Battery from the NIH Toolbox [33,34])
or fully (e.g., the Cambridge Neuropsy-
chological Test Automated Battery [35])
computerized are primarily appropriate
for use in research. Growing evidence
that performance measures of cogni-
tion (including EF) contribute to glyce-
mic control, and that diabetes itself has
a deleterious impact on cognition (36),
suggest that neuropsychological evalu-
ations may be beneficial in identifying
those who are at risk for poor health
outcomes. Such evaluations, together
with tailored feedback, have been asso-
ciated with improved patient outcomes
in a variety of settings (37).
The results of this study should be
interpreted in the context of some lim-
itations. First, although we used a com-
posite of eight EF performance–based
scores, we did not comprehensively as-
sess all aspects of the EF construct,
especially emotional control and deci-
sion making (19). Second, we assessed
EF performance at only one time point.
Although the longitudinal design of
the study provides some assurance
that EF performance did affect changes
in HbA1c, emerging adulthood is a time
when EF is still developing. Because
deteriorations in HbA1c and the fre-
quency of severe hypoglycemia may
have consequences for cognitive func-
tion (36), additional research reassessing
EF during emerging adulthood is neces-
sary in order to understand the bidi-
rectional associations between EF and
glycemic control (36). Third, the majority
of teens in the sample had parents who
had attained at least some college edu-
cation, which may limit generalizability
to teens who have fewer advantages
and whose EF may have been negatively
affected by low socioeconomic status
(38). Finally, by design, our participants
were enrolled during their senior year
of high school (ages 17 and 18 years),
which limits the generalizability of the
findings to those of other ages.
Table 3—Growth Curve Model for Adherence
Components of adherence growth
curve models
Adherence
Random effect Varianceb SE
Unconditional model
Intercept 0.604 0.008** 0.010 0.001**
Time (0 = time 1) 20.012 0.005* 0.002 0.001**
Conditional models
EF performancea
Intercept 0.604 0.008** 0.010 0.001**
Time (0 = time 1) 20.011 0.005* 0.002 0.000**
IQ
On Intercept 0.000 0.003
On Slope 0.001 0.002
EF performance
On Intercept 0.005 0.005
On Slope 0.000 0.003
Self-reported EF problemsa
Intercept 0.604 0.008** 0.009 0.001**
Time (0 = time 1) 20.010 0.005 0.002 0.000**
IQ
On Intercept 0.000 0.002
On Slope 0.001 0.001
Self-reported EF problems
On Intercept 20.004 0.001**
On Slope 0.000 0.000
All units are proportions as adherence ranges from0–1. aControlling for IQ. *P, 0.05; **P, 0.01.
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In sum, this study demonstrates that
EF is a resource for good glycemic con-
trol across the high-risk time of emerg-
ing adulthood. The challenges that
emerging adults with low EF face may
be compounded by the concomitant
decline in parental involvement that
often occurs during this time. Early
emerging adults (especially those with
low EF abilities) may benefit from mul-
tiple supports for diabetesmanagement,
such as text-based reminders (39) and
the support and assistance that parents,
friends, and health care providers may
provide, in order to facilitate their ad-
herence behaviors and maintain good
glycemic control during this transitional
time (40).
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